Patents Assigned to HISTAPHARM INC.
  • Patent number: 9878020
    Abstract: The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme formulations include at least one histaminase and various methods of treatment of physical conditions, such as inflammation, allergy, histamine intolerance, and intestinal cancer.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: January 30, 2018
    Assignee: Histapharm Inc.
    Inventors: Mircea-Alexandru Mateescu, Carmen Calinescu, Pompilia Ispas-Szabo, Bruno Mondovi, Rodolfo Federico
  • Publication number: 20140212492
    Abstract: The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme formulations include at least one histaminase and various methods of treatment of physical conditions, such as inflammation, allergy, histamine intolerance, and intestinal cancer.
    Type: Application
    Filed: April 5, 2012
    Publication date: July 31, 2014
    Applicant: HISTAPHARM INC.
    Inventors: Mircea-Alexandru Mateescu, Carmen Calinescu, Pompilia Ispas-Szabo, Bruno Mondovi, Rodolfo Federico